Author:
Klawansky Sidney,Burdick Elisabeth,Adams Miriam,Bollini Paola,Orza Michele,Falotico-taylor Jennifer
Abstract
AbstractThe Surveillance, Epidemiology, and End Results (SEER) cancer registry contributed to technology assessment by providing population-based samples for detailed case-control studies, by serving as the control group in comparisons with various experimental groups, by allowing an assessment of selection bias in clinical trials, and by facilitating evaluations of classification and coding systems.
Publisher
Cambridge University Press (CUP)
Reference36 articles.
1. The histological grading of neoplasms;Henson;Archives of Pathology and Laboratory Medicine,1988
2. Breast Cancer Incidence and Mortality in the Breast Cancer Detection Demonstration Project
3. The argument for a combined cancer consortium research data base
4. Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience.
5. Hodgkin's disease in the United States: A comparison of patient characteristics and survival in the Centralized Cancer Patient Data System and the Surveillance, Epidemiology, and End Results Program;Davis;Journal of the National Cancer Institute,1987
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献